Align Technology, Inc.

Align Technology, Inc.(ALGN)股票分析

$157.580

-1.245 (-0.79%)收盘时

Loading chart…
High
159.965
Open
158.510
VWAP
158.25
Vol
954.65K
Mkt Cap
18.29B
Low
157.210
Amount
151.07M
EV/EBITDA, TTM
10.85

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

AI analysis of Align Technology, Inc. (ALGN)

hold

Align Technology Inc is currently not a strong buy due to its low RSI of 27.223, indicating it is oversold, and a recent price drop of 3.06% over the last five days. However, analysts have set a price target as high as $230, suggesting potential upside. The main risk is the current price of $157.58, which is below the recent highs and reflects market uncertainty.

Analyst Ratings (11)

+26.09% upside
Buy
11 Buy
0 Hold
0 Sell
Current: 157.58
最低
169.00
平均
198.70
最高
220.00

UBS

2026-07-23

目标价

$189

Neutral

BMO Capital

2026-07-08

目标价

$209

Outperform

Leerink

2026-06-30

目标价

$230

Outperform

Leerink

2026-05-27

目标价

Outperform

Morgan Stanley

2026-04-24

目标价

$188

Equal Weight

估值指标

The current forward P/E ratio for Align Technology, Inc. (ALGN) is 14.08, compared to its 5-year average forward P/E of 28.49.

Forward P/E

Fair
5Y Average P/E
28.49
Current P/E
14.08
高估
42.94
低估
14.04

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
19.34
Current EV/EBITDA
10.85
高估
28.10
低估
10.58

Forward P/S

Fair
5Y Average P/S
5.12
Current P/S
2.60
高估
7.68
低估
2.55

Alphio AI Price Scenarios for ALGN

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ALGN

$210.76

情景价格

B

Base

Base · 50%ALGN

$171.10

情景价格

B

Bear

Bear · 25%ALGN

$159.37

情景价格

Whales holding ALGN

A

Armistice Capital LLC

+ HoldingALGN

+13.92%

3M Return

B

Bellevue Asset Management AG

+ HoldingALGN

+9.20%

3M Return

V

Veritas Investment Management LLP

+ HoldingALGN

+4.58%

3M Return

C

Carmignac Gestion SA

+ HoldingALGN

+3.23%

3M Return

N

Ninety One UK Limited

+ HoldingALGN

+2.96%

3M Return

C

Country Trust Bank

+ HoldingALGN

+2.45%

3M Return

事件时间线

2026-08-12 (ET)

05:30:00

Align Wins Patent Infringement Case in China, Awarded RMB 10M

2026-07-29 (ET)

20:30:00

Major US Indices Close Lower, Semiconductor Stocks Plummet

17:00:00

Align Technology Increases 2026 Share Repurchase to $400M-$500M

17:00:00

Align Technology Reports Q2 Revenue of $1.056B

17:00:00

Align Adjusts 2026 Revenue Guidance, Expects $400M to $500M Stock Buyback

资讯

ALGN FAQ — answered by Alphio AI

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Align Technology Inc is currently not a strong buy due to its low RSI of 27.223, indicating it is oversold, and a recent price drop of 3.06% over the last five days. However, analysts have set a price target as high as $230, suggesting potential upside. The main risk is the current price of $157.58, which is below the recent highs and reflects market uncertainty.

11 analysts cover ALGN: 11 rate it Buy, 0 Hold and 0 Sell. The average price target is 198.70.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始